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Background. Clinical Diagnostic Care Pathways (CDCP) are 
management tools widespread throughout the world to improve 
the quality of patient care through a well-organized care con-
tinuum and to enhance the patient’s “risk-adjusted” outcomes; 
indeed they could optimize the management of resources. They 
are particularly effective in the management of patients with 
chronic degenerative diseases, such as chronic kidney disease, 
with increasingly incidence and prevalence, with an estimated 
11-13% of the population being affected. The aim of this study 
is to apply the Health Services Research methods to estimate the 
relationship between need, demand and supply in patients with 
stage 5 Chronic Kidney Disease (CKD) for, then to describe the 
definition of a CDCP dedicated to patients in Lazio Region , so 
to allow an appropriate patient management, to reduce the likely 
complications and the patients’ migration to facilities outside 
the region. 
Methods. The study was conducted in 2017 in collabora-
tion between the National Institute of Health, the University of 
Messina and the S. Giovanni Addolorata Hospital.
Results. We analyzed the data for the CKD in Roma and in the 
San Giovanni Addolorata Hospital Trust and we found a drop out 
in the patients’ attendance towards other regions and/or hospitals. 
So we defined a CDCP to be adopted at the San Giovanni Addo-
lorata hospital.
Conclusions. To define management and care tools to provide ade-
quate, efficient and patient centered care is a nowadays “must”, to 
ensure the sustainability of the Italian NHS, which today is compa-
rable to a “ship that is heading towards a perfect storm”. 
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Today, the right to health is universally recognized: each 
Country has in fact ratified at least one of the interna-
tional human rights treaties sanctioning it  [1]. Health-
care, however, is provided differently on different con-
tinents, ranging from private systems with the need for 
insurance coverage by citizens, as in the US, to public 
systems with costs borne by the National Health Ser-
vice as in Italy, where public funds support healthcare 
provision [2]. All developed countries are putting more 
resources into health, but this increased investment is 
totally inadequate to meet the steady increase in com-
munity needs; which is primarily due to a change in the 
population that is “growing older” and as life expectancy 
increases so does the number of subjects with chronic de-
generative diseases who require access to treatment [3]. 
This is linked to the greater availability of new and more 
expensive diagnostic technologies; since health is an as-
set to be safeguarded and all citizens, regardless of age, 
must be assured equal treatment opportunities. Thus, the 
demand for health care (and consequently the costs) is 
ever-increasing creating a vicious circle [4]. The contin-
uous effort to improve health therefore requires the per-
formance of healthcare systems and policies be meas-
ured, with subsequent adaptation of the system based on 
the assessment. Given the limited availability of funds in 
Italy, their correct and timely management is vital. This 
necessitates a well-structured therapeutic diagnostic 
process and this is where Clinical Diagnostic Care Path-
ways (CDCP) come into play. CDCPs are widespread 
throughout the world and their objectives are to improve 
the quality of patient care through a well-organized care 
continuum , and to enhance the patient’s “risk-adjusted” 
outcomes; the third objective is to optimize the manage-
ment of resources, not only economic but also structural 
and human [5, 6]. One of the most widespread chronic 
degenerative diseases is chronic kidney disease (CKD), 
and its incidence and prevalence is increasing world-
wide: with an estimated 11-13% of the population being 
affected by CKD, particularly stage 3 [7]. Once the ter-
minal stage of the disease has been reached, the patient 
must undergo renal replacement therapy by specialized 
dialysis. The main replacement methods of renal func-
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tion are hemodialysis and peritoneal dialysis. In 2010, 
284 individuals per million population were estimated 
to be receiving maintenance dialysis in the world. Al-
though the use of peritoneal dialysis is increasing in 
some countries, including China, United States and 
Thailand, it has proportionally decreased in parts of Eu-
rope and in Japan [8, 9]. Well-functioning vascular ac-
cess is a prerequisite for good dialysis treatment; vascu-
lar access failure (VAF) is the most common reason for 
hospitalization among hemodialysis (HD) patients. The 
economic burden of VAF is estimated to exceed 1 bil-
lion dollars per year and continues to rise. The possible 
acute complications related to vascular access (bleeding, 
stenosis and/or thrombosis, AVF malfunction, malfunc-
tion, dislocation, central venous catheter (CVC) infec-
tion) must be managed in a specialized environment and 
by highly specialized personnel [10-12]. Arterio-venous 
fistula (AVF) with native vessels is the preferred method 
of vascular access as it allows greater survival, reduced 
risk of infection and fewer complications. The Kidney 
Disease Outcomes Quality Initiative (KDOQI) guide-
lines recommend packing vascular access when creati-
nine exceeds 4 mg/dL or when the Glomerular filtrate is 
less than 25 ml/min (Guideline 8 of KDOQI) and at least 
one month before (better 3-4 months) cannulation [13]. 
In the Italian region of Lazio at 31/12/2015 there were 
90 outpatient facilities providing dialysis services (“di-
alysis centers”), 37 public and 53 private, with a non-ho-
mogeneous coverage across the region. This wide supply 
availability induces high patient mobility in Rome area, 
with patients migrating towards dialysis centers located 
in healthcare districts other than that of residence. This 
phenomenon is also found in the other municipalities of 
Lazio, albeit to a lesser extent. Over the period 2008-
2013, the rate of first hospital admissions in Lazio re-
gion due to cardio-circulatory problems was 21.0%, and 
a mortality rate of 20.9%, both within two years from 
the start of dialysis. Even taking into account the uneven 
distribution of clinical and demographic features among 
patients treated according to the P.Re.Val.E procedure 
(risk adjustment), there remains inconsistency between 
dialysis centers and areas of residence [14]. The aim of 
the present study is to: 1) analyse according to a Health 
Services Research perspective the relationship between 
need, demand and supply for patients with stage 5 CKD 
in a given area in Rome [15]; b) to define a clinical di-
agnostic care pathway for patients in the Lazio region 
that allows, first, a more appropriate and timely patient 
management by all medical figures involved, to to re-
duce the likely disease complications and, secondly, a 
reduction in patients’ migration to facilities outside the 
region; c) to build up a monitoring system to evaluate the 
forthcoming impact of the implementation of the CDCP.
Materials and methods
The Health Services Research analysis was conducted 
in collaboration between the Istituto Superiore di Sanità 
(National Institute of Health), the University of Messina 
and the Complex Operative Unit of Vascular Surgery at 
the S. Giovanni Addolorata Hospital, a Hospital Trust 
in Rome metropolitan area. The database used was the 
national database of Hospital Discharge Cards (SDO) 
available at the ISS Statistical Technical Service, pro-
vided by the Ministry of Health. Reasons for hospitaliza-
tion are classified by means of the international system 
called the ICD-9 CM (International Classification of 
Diseases - Clinical Modification), which is also used in 
Italy (the latest version is 2007) [16].
The analysis was carried out in November-December 
2017 and covered residents in the Lazio Region admit-
ted to facilities in the Lazio Region and to the San Gio-
vanni Addolorata Hospital, in particular. The years ana-
lyzed were 2015 and 2016 with prevalent cases counted 
separately for these two years. The analysis covered 
both inpatients and outpatients; in order to obtain the 
most accurate estimate of the prevalence of pathologi-
cal conditions. The SDO database was considered in its 
entirety including daytime admissions, while naturally 
excluding long-term hospitalizations and rehabilitations. 
Each SDO reports a “Diagnosis/main procedure” and up 
to five “secondary diagnoses/procedures”(Law Decree 
380/2000). The database was queried for all the diag-
nosis/procedure fields thereby enabling the number of 
cases to be estimated more accurately.
Results
The application of the Health Services 
Research approach 
The resident population in Lazio was 5,898,124 inhab-
itants at 31/1/17 (ISTAT data) and the total number of 
patients with stage 5 CKD (eg, Lazio cod. 5856) was 
2,116 for the year 2016 (SDO data). Thus, the estimated 
prevalence of the disease stage in Lazio was 0.036% for 
the year 2016. The number of patients admitted under 
IRC cod 5856 were 2,695 and 2,926 for the years 2015 
and 2016 respectively, with the number of admissions 
with severe complications of 1,757 and 1,826. 
The population served by S. Giovanni Addolorata Hos-
pital is 413,749 inhabitants, thus the predicted number 
of patients at the San Giovanni-Addolorata hospital with 
CKD Cod. 5856 (to be estimated according to the SDO 
database) is approximately 148.4. However, the number 
of patients treated was 90 and 102 for the years 2015 
and 2016 respectively (estimated according to the SDO 
database). This means a likely migration of stage 5 CKD 
patients to other centers of as many as 46 patients for the 
year 2016. A more focused analysis of the data available 
showed migration to facilities outside the Lazio region 
of 6.3% of cases for the year 2015 and 6.4% of cases for 
the year 2016. The results obtained are summarized in 
Tables I and II.
The definition of the CDCP 
The clinical pathway must be the tool to sensitize the 
problem of the “life line” of the uremic patient starting 
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with the family physician who will single out which pa-
tients to send to the nephrologist to plan for the crea-
tion of a usable vascular access when the need arises 
for dialysis. It will be the nephrologist who will iden-
tify when the vascular surgeon will have to perform the 
surgery. The emergency doctor of the first aid who will 
manage the acute uremic patient through nephrological 
counseling, and will activate the path for urgent vascular 
or endovascular surgical treatment in order to avoid the 
insertion of a central venous catheter unless absolutely 
indispensable. It will be necessary to sensitize the he-
modialysis centers of the territory on which the hospital 
company insists, in order to inform them of the possibil-
ity of using a 24-hour service for the management of 
complications of vascular access or for the creation of 
complex arteriovenous fistulas. It is therefore necessary 
to create an interdisciplinary team consisting of: emer-
gency doctor, nephrologist, vascular surgeon and inter-
ventional radiologist. The aims of the clinical pathway 
are as follows:
• optimization of patency surveillance, the correct 
planning of vascular access packaging and avoiding 
the insertion of CVC for acute hemodialysis;
• reducing the number of uremic patients requiring ur-
gent hemodialysis treatment, without vascular access 
(avoiding the insertion of central venous catheters 
that are linked to high morbidity in terms of infection 
and thrombosis of central veins thereby compromis-
ing the feasibility of future vascular accesses for he-
modialysis);
• reducing the number of patients who acutely need 
revision of vascular access due to occlusion/throm-
bosis or malfunction (avoiding urgent repacking and 
insertion of CVC);
• intercepting patients with acute occlusion of the vas-
cular access for surgical or endovascular correction 
in order to restore the functionality or eventual pack-
aging of arteriovenous prosthetic fistula “early can-
nulation” in order to avoid insertion of CVC;
• avoiding extra-regional migration of hemodialysis 
patients who have difficulty accessing vascular sur-
geries in Lazio;
• clinical surveillance of vascular accesses for the ear-
ly diagnosis of dysfunction in the dialysis room, with 
the aid of instrumental diagnostics (Color Doppler 
ultrasound, angiography);
Tab. I. Admissions and procedures in the Lazio Region and San Giovanni Addolorata hospital.
Lazio Year 2015 Year 2016
Number of admissions for CKD (cod. 5856) 2,695 2,926
Number of admission for complications (V56.1, V56.2, 996.1, 996.62, 996.73) 1,757 1,826
Number of surgical procedures (39.27, 39.49, 39.50, 39.52, 39.29, 39.42, 39.43, 38.95, 86.07) 10,923 11,393
Numbers of surgical procedures outside region
Cod. 39.27, 39.49, 39.50, 39.52, 39.29, 39.42, 39.43, 38.95, 86.07 
703 780
Numbers of patients with CKD at end stage cod.5856 1,961 2,116
San Giovanni Addolorata 
Number of admissions cod. 5856 90 102
Number of admissions 82 84
Number of surgical procedures ( 39.27, 39.49, 39.50, 39.52, 39.29, 39.42, 39.43, 38.95, 86.07) 372 495
Number of admissions for complications (V56.1, V56.2, 996.1, 996.62, 996.73 ) 8 7
Tab. II. Codex of procedures and complications.
Procedures and complications Cod.
Numberof admissions for CKD 5856
Number of admission for complications
Placement and arrangement of extracorporeal dialysis catheter V56.1
Positioning and arrangement of peritoneal dialysis catheter V56.2
Mechanical complications of other devices, implants and vascular grafts. 996.1
Infection of vascular grafts 996.62
Other complications from prostheses, implants and renal dialysis grafts 996.73
Number of surgical procedures
Arteriovenostomy for renal dialysis 39.27
Other revision of vascular interventions 39.49
Angioplasty or atherectomy of a non-coronary vessel 39.50
Other repair of aneurysms 39.52
Other vascular anastomoses or by-pass (peripheral) 39.29
Revision of arterio-venous anastomoses for renal dialysis 39.42
Removal of A-V anastomosis for renal dialysis 39.43
Venous catheterization for renal dialysis 38.95
Insertion of a totally implantable vascular access device 86.07
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• using the resources of 24-hour centers to deal with 
vascular access complications and to restore the pa-
tency and usability of the arteriovenous fistula as 
soon as possible. The “Quick access” CDCP com-
plies with the National Kidney Foundation KDOQI 
guidelines and those of the Italian Society of Vascu-
lar and Endovascular Surgery [17, 18].
The aforementioned CDCP has therefore been adopted 
as a model in the San Giovanni Addolorata hospital and 
the reduction of outpatient migration and emergency 
hospital access have been included in the CDCP moni-
toring plan and are currently being monitored.
Discussion and conclusions
By applying the Health Services Research approach, 
we found that patients admitted with a IRC coding were 
2,695 and 2,926 for the years 2015 and 2016, respective-
ly, with the number of admissions with severe complica-
tions of 1,757 and 1,826. Thus, a unsatisfactory manage-
ment of the uremic patient by both general physicians 
and specialists would be underlined.
In addition, 6.3% of cases of patients with stage 5 KCD 
in 2015 and 6.4% of cases in 2016 accessed to facilities 
outside the Lazio region. 
In addition, our analysis highlights shortcomings in pa-
tient management, despite the professional and structur-
al resources available so to induce a high extra-regional 
migration for surgical procedures, that is reasonably not 
due to boundary migration. This is particularly heavy for 
patients with CKD and for their carers and is unaccep-
table for a region where specialized facilities and highly 
qualified personnel are available.
It is evident from clinical practice that the problems re-
lated to the packaging and maintenance of a vascular 
access usable for satisfactory hemodialysis are often ne-
glected, despite their importance in terms of social and 
health impact. Since this surgical technique is specific 
to terminal uremic patients, while referrals for surger-
yare made only by the nephrologist, it is difficult for the 
vascular surgeon, to respond promptly to a demand for 
treatment. Complex vascular surgery units often have no 
specific competence and demand from the nephrologist 
the packaging of native arteriovenous fistulas, but at the 
same time, they are called upon to solve urgent com-
plications for which complex surgical or endovascular 
procedures are required. The result is an erratic and im-
precise management in a “no man’s land” that endangers 
the “life line” of the uremic patient, that is the Arterio-
venous Fistula. It is therefore necessary, in our opinion, 
to delineate a care path that identifies a multidisciplinary 
team that will deal with all these patients, to plan the 
packaging of the vascular access and maintain its pa-
tency through clinical surveillance. This will lead to the 
reduction of complications related to any malfunction 
and reduce the need to insert CVC that compromise the 
quality of efferent blood vessels.
It is also necessary for diagnostic and therapeutic proce-
dures to be implemented in environments where the pa-
tient’s response can be constant within 24 hours. A sys-
tematic review and meta-analysis demonstrated a trend 
toward the benefit of the rate of thrombosis and access 
to patients with usual clinical monitoring [19]. Compli-
ance with international guidelines, approved by the Ital-
ian scientific societies of nephrology and vascular and 
endovascular surgery, guarantees the correctness of pro-
cedures and result in improved outcomes  [17, 18, 20]. 
Despite the presence of numerous hemodialysis cent-
ers and the same number of Vascular surgery units in 
the Lazio region, the data provided by the SDO cards, 
show an alarmingly high a number of urgent hospitali-
zations for chronic renal insufficiency that suggest in-
correct planning and classification of uremic patients 
from that area. There is also a frequent need for urgent 
dialytic treatment and therefore the insertion of CVCs 
and vascular access packaging in post-acute conditions 
and this involves the reduction of the superficial venous 
heritage of the upper limbs for repeated venipuncture. 
All this translates into increased morbidity related to 
vascular access and a reduction of long-term patency, as 
also demonstrated by the existing literature [21]. These 
shortcomings in patient management, despite the profes-
sional and structural resources present, mean that there 
is also a discouraging and disconcerting fact:. a need for 
a prompt, timely and appropriate treatment, is not en-
countered by the supply system and its causes a high 
extra-regional migration for surgical procedures, that is 
reasonably not due to boundary migration. This is par-
ticularly heavy for patients with CKD and for their car-
ers and is unacceptable for a region where specialized 
facilities and highly qualified personnel are developed 
and recognized by the scientific community! 
Therefore, an appropriate management of the uremic 
patient is necessary both by general practitioners and by 
nephrologists with the creation of an adequate care path. 
The early management of the patient with CKD and the 
sharing with the nephrologist of these patients constitute 
the pivot on which the different levels of care are articu-
lated; with at least three possible different levels of care: 
region, outpatient and hospital management. Each of the 
three levels is not an end in itself, but may overlap with 
others depending on the patient’s clinical status, any com-
plications and accelerations [13]. In order for care to be 
efficient, the creation of a clinical diagnostic care path 
based on the coordinated synergy of different profes-
sional figures is necessary to guarantee and enhance its 
effectiveness with the formulation of clear recommenda-
tions for shared management, to be reviewed periodically 
with any updates to be implemented, as new evidence 
arises [22, 23]. To enhance integration and continuity of 
care, the creation of shared data platform between the 
GP and the nephrologist is welcome as crucial to allow a 
useful exchange of information between the profession-
als involved and the monitoring of the process through 
shared indicators, in line with current Ministry of Health 
guidelines [24].
The optimization of patient management and the organi-
zation of adequate health care is therefore essential to 
ensure the sustainability of the Italian NHS, which today 
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is comparable to a “ship that is heading towards a perfect 
storm” [25, 26].
Some limitations of our study must be acknowledged. 
One limitation of the present study is the partial retro-
spective collection of cases. 
Another one is due to the use of administrative data (eg, 
the SDO database) for epidemiological purposes, to de-
scribe the relationship between needs, demand and sup-
ply of care for patients with KCD. The national database 
of the SDO doesn’t receive informations on the inci-
dence, residences adress and it isn’t possible to reason 
on the mobility of patients inside the area of Rome.
In addition, by calculating “incidence”, we didn’t ana-
lyse the likely increase over the years or other factors 
with an expected impact on access to care. 
Such limitations in data source and integration also lim-
ited us in the analysis of an adequate relationship between 
demand and supply, that is of primary importance in a 
National Health Service like the Italian, were the free of 
choice of patients towards of providers of care in the health 
sectors care is an underpinning principle. We are confident 
that such a risk would be avoided by applying a ZIP code 
analysis or by studying patterns of patients fluxes due to 
other determinants by applying marketing strategies [27], 
internal “leaks” within the city of Rome, surveys on the 
customer preferences towards the delivery facilities. On the 
other hand, we consider of crucial importance to propose 
a quantitative approach to evaluate the capability to satisfy 
healthcare needs and to perform an advocacy role towards a 
better management of patients with CKD, who are at higher 
risk of inequalities and lower access to care in a period of 
economic costraints and of management weakness, as a 
consequence of the “perfect storm” [26]. 
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